Evidence map›Paper›PMID 38775470›Full record

ReviewJournal of clinical microbiology2024

Proceedings of the Clinical Microbiology Open 2023: discussions about pandemic preparedness.

Eleanor A Powell, Alexander L Greninger, Elizabeth M Marlowe, Samia N Naccache, Christopher D Doern

Abstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eleanor A PowellDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio, USA.ORCID 0009-0005-8641-7708
Alexander L GreningerDepartment of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA.
Elizabeth M MarloweQuest Diagnostics, San Juan Capistrano, California, USA.ORCID 0000-0002-7023-5193
Samia N NaccacheDepartment of Microbiology, LabCorp, Seattle, Washington, USA.
Christopher D DoernDepartment of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 4th Clinical Microbiology Open (CMO) took place in Carlsbad, California, on 10 and 11 February 2023. This event facilitated discussion between clinical and public health laboratory directors, government agencies, and industry representatives from the companies that make up ASM's Corporate Council. While many topics were discussed, much of the discussion focused on pandemic preparedness. There were four major questions addressed: (i) When is the perfect the enemy of good in pandemic testing? (ii) What other types of pathogens might cause another pandemic and how would this affect laboratory response? (iii) What research is needed to better understand the effectiveness of the pandemic response? (iv) What have we learned about the utility of self and at-home testing in future pandemics? This review serves as a summary of these discussions.

Indexed as

PandemicsCOVID-19HumansPandemic Preparednesspandemic preparednessSARS-CoV-2

Identifiers

PMID38775470
PMCPMC11237618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.